Medications

Octaplas approved for blood-clotting disorders

(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.

Diseases, Conditions, Syndromes

Restrictive transfusion strategy safe for acute GI bleeding

(HealthDay)—For patients with severe acute gastrointestinal bleeding, a restrictive transfusion approach is safe and effective compared with a liberal approach, according to a study published in the Jan. 2 issue of the ...

Diseases, Conditions, Syndromes

One man's harrowing battle with hepatitis C

(HealthDay)—Ted Adamson's liver had been so ravaged by the hepatitis C virus that he was nearly at the point of needing a liver transplant. Yet he had no symptoms. None. He didn't even feel tired.

Health

Omega-3 supplements don't increase surgical blood loss

(HealthDay)—Omega-3 fatty acid (n-3FA) supplements do not correlate with higher perioperative blood loss during spinal fusion procedures, according to a study published in the December issue of the European Spine Journal.

Surgery

Cell saver not cost-effective in single-level lumbar surgery

(HealthDay)—Use of intraoperative blood salvage (cell saver) is not cost-effective for adult patients undergoing single-level posterior lumbar decompression and fusion (PLDF) surgery, according to research published online ...

Diseases, Conditions, Syndromes

Creutzfeldt-Jakob, 'Mad Cow' blood test now on the horizon

(Medical Xpress)—A simple blood test for Creutzfeldt-Jakob Disease and Mad Cow disease is a step closer, following a breakthrough by medical researchers at the University of Melbourne.

page 22 from 30